The Valley Desk

NCT06333899 · Interventional trial

Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

Overall registry status Recruiting

Early Phase 1

Conditions Anaplastic Astrocytoma, Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, H3K27-altered, Glioblastoma, Glioblastoma Multiforme, High Grade Glioma, Infant Type Hemispheric Glioma, WHO Grade III Glioma, WHO Grade IV Glioma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov